CanPoland SA

info@canpoland.com

CANPOLAND SA WITH GMP CERTIFICATE

CANPOLAND SA WITH GMP CERTIFICATE 150 150 CanPoland SA

CanPoland SA with GMP certificate

The trust that CanPoland SA customers have placed in the brand for a long time has also been confirmed by the Office of the Chief Pharmaceutical Inspector. A company with an established position in the cannabis industry, as evidenced by, among others its dynamic development, received the Good Manufacturing Practice certificate. It confirms the highest production standards.
The GMP certificate granted to CanPoland SA covers the scope of the secondary packaging service. This means that the manufacturer can repack sterile, non-sterile products and also certify the batches in this regard - after undergoing this process, the product may be sold on the Polish or foreign market. In addition, the GMP certificate also includes the procedure for repacking controlled substances (narcotic and psychotropic substances). This means that the service of repackaging for parallel import of medicinal products, performed by CanPoland SA, meets the highest quality standards. What is a GMP certificate? Producers wishing to provide their customers with the highest standard of service and quality of delivered products may apply for confirmation of the effectiveness of their practices in the form of a Good Manufacturing Practice certificate. Granting it before the appropriate office is to ensure that the goods offered by the company are not only of the highest quality and are safe to use, but also their production is distinguished by impeccable conditions and consistency. The Good Manufacturing Practice Certificate is issued in Poland by the office of the Chief Pharmaceutical Inspector. According to the information presented on the official website of the authority, this is a certificate which is to confirm the compliance of the manufacturing conditions with the requirements of Good Manufacturing Practice. The document is granted at the request of the manufacturer or importer of medicinal products, investigational medicinal products, or the manufacturer of active substances. To obtain a certificate, it is predisposed to carry out an inspection, which must be completed with a positive result. The document may cover either a single stage of the production process or its entirety. The GMP certificate is granted for three years, after which - after another inspection - its validity may be extended. Obtaining the GMP certificate confirms that the manufacturer meets the highest standards of pharmaceutical production. Producers with a Good Manufacturing Practice certificate appear in the EU EudraGMDP database.

https://canpoland.com/en/canpoland-sa-with-gmp-certificate/
CanPoland SA with the keynote speech at Cannabis Business Europe 2021 150 150 CanPoland SA

CanPoland SA with the keynote speech at Cannabis Business Europe 2021

We are pleased to announce that CanPoland SA will take part in the conference for cannabis industry leaders – Cannabis Business Europe 2021. The event will be held on June 22-23 in Germany, in Frankfurt. Over 70 companies are taking part in the conference. These will be businesses and experts not only from Europe, but…

read more
CanPoland Clinics with the first location 150 150 CanPoland SA

CanPoland Clinics with the first location

A subsidiary of CanPoland SA – CanPoland Clinics – is opening the first clinic. The medical center will be opened in Warsaw at al. KEN 103, next to the Ursynów metro station in Q3 2021. The clinic will be ready in Q3 2021. There will be four offices and a space for patients on the…

read more
CanPoland SA’s plans concerning its debut on the stock exchange 150 150 CanPoland SA

CanPoland SA’s plans concerning its debut on the stock exchange

Łódź, May 11th, 2021 CanPoland SA’s plans concerning its debut on the stock exchange The management board of the CanPoland SA, a leading Polish pharmaceutical company operating on the medical marijuana market, announced that it has begun the search for a brokerage house and consulting company that will support the CanPoland in the process of…

read more
Development Plans of CanPoland SA 150 150 CanPoland SA

Development Plans of CanPoland SA

Łódź, May 4th, 2021 CanPoland SA’s plans concerning domestic and foreign expansion The management board of the CanPoland SA company, a leading Polish pharmaceutical company operating on the medical marijuana market, announced the company’s plans for its development: both its geographic and operational. The plans have already been accepted by the company’s supervisory board and…

read more

    Ta strona używa plików cookie w celu usprawnienia i ułatwienia dostępu do serwisu oraz prowadzenia danych statystycznych. Dalsze korzystanie z tej witryny oznacza akceptację tego stanu rzeczy.
    Polityka Cookies